Search Results - "Mebis, J."

A phase II randomized trial of cobimetinib plus chemotherapy, with or without atezolizumab, as first-line treatment for patients with locally advanced or metastatic triple-negative breast cancer (COLET): primary analysis by Brufsky, A., Kim, S.B., Zvirbule, Ž., Eniu, A., Mebis, J., Sohn, J.H., Wongchenko, M., Chohan, S., Amin, R., Yan, Y., McNally, V., Miles, D., Loi, S.

“…Resistance to standard chemotherapy in metastatic triple-negative breast cancer (mTNBC) is associated with upregulation of the mitogen-activated protein kinase…”
Get full text

Cancer therapy-related vaginal toxicity: its prevalence and assessment methods-a systematic review by Claes, Marithé, Tuts, L, Robijns, J, Mulders, K, Van De Werf, E, Bulens, P, Mebis, J

“…In 2020, almost 9 million women were diagnosed with cancer worldwide. Despite advancements in cancer treatment strategies, patients still suffer from acute and…”
Get full text

Efficacy of olaparib in advanced cancers with germline or somatic mutations in BRCA1, BRCA2, CHEK2 and ATM, a Belgian Precision tumor-agnostic phase II study by Joris, S., Denys, H., Collignon, J., Rasschaert, M., T’Kint de Roodenbeke, D., Duhoux, F.P., Canon, J.-L., Tejpar, S., Mebis, J., Decoster, L., Aftimos, P., De Grève, J.

“…The Belgian Precision initiative aims to maximize the implementation of tumor-agnostic next-generation sequencing in patients with advanced cancer and enhance…”
Get full text

PO-0688: Patterns of LR for stage III N2 NSCLC patients after chemotherapy and surgery: implications for PORT by Billiet, C, De Ruysscher, D, Peeters, S, Decaluwé, H, Vansteenkiste, J, Dooms, C, Deroose, C.M, Hendrikx, M, Mebis, J

Get full text

Changes in anticancer treatment plans in patients with solid cancer hospitalized with COVID-19: analysis of the nationwide BSMO-COVID registry providing lessons for the future by Geukens, T., Brandão, M., Laenen, A., Collignon, J., Van Marcke, C., Louviaux, I., Demey, W., Van Wambeke, S., Schrijvers, D., Lecomte, S., Mebis, J., Rutten, A., Fontaine, C., Lybaert, W., Aspeslagh, S., Goeminne, J.-C., Van Den Bulck, H., Seront, E., De Backer, L., De Roock, W., Ignatiadis, M., Prenen, H., Van Beckhoven, D., Heijlen, M., Verheezen, J., Rottey, S., Punie, K., de Azambuja, E.

“…Solid cancer is an independent prognostic factor for poor outcome with COVID-19. As guidelines for patient management in that setting depend on retrospective…”
Get full text

1617 An observational time and motion study of denosumab subcutaneous injection and zoledronic acid intravenous infusion in patients with metastatic bone disease: Results from Belgium and Germany by Body, J.J, Gatta, F, Peteers, M, Wimberger, P, Mebis, J, Sommer, U, Besse-Hammer, T, De Cock, E, Tao, S, Kritikou, P, Hechmati, G

Get full text

PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment by Thouvenin, J., Van Marcke, C., Decoster, L., Raicevic, G., Punie, K., Vandenbulcke, M., Salgado, R., Van Valckenborgh, E., Maes, B., Joris, S., Steichel, D. Vander, Vranken, K., Jacobs, S., Dedeurwaerdere, F., Martens, G., Devos, H., Duhoux, F.P., Rasschaert, M., Pauwels, P., Geboes, K., Collignon, J., Tejpar, S., Canon, J.-L., Peeters, M., Rutten, A., Van de Mooter, T., Vermeij, J., Schrijvers, D., Demey, W., Lybaert, W., Van Huysse, J., Mebis, J., Awada, A., Claes, K.B.M., Hebrant, A., Van der Meulen, J., Delafontaine, B., Bempt, I. Vanden, Maetens, J., de Hemptinne, M., Rottey, S., Aftimos, P., De Grève, J.

“…PRECISION is an initiative from the Belgian Society of Medical Oncology (BSMO) in collaboration with several stakeholders, encompassing four programs that aim…”
Get full text

4031 POSTER Evaluation of the Groningen Frailty Indicator as a Screening Tool for Frailty in Older Cancer Patients (pts) by Baitar, A, Van Fraeyenhove, F, Galdermans, D, Mebis, J, Schrijvers, D

Get full text

4006 ORAL Evaluation of the G8 Questionnaire as a Screening Tool for Frailty In Older Cancer Patients (pts) by Baitar, A, Vandebroek, A, De Droogh, E, Mebis, J, Schrijvers, D

Get full text

Antibiotic Management of Febrile Neutropenia: Current Developments and Future Directions by Mebis, J., Goossens, H., Berneman, Z.N.

“…Mortality due to febrile neutropenia has decreased since the concept of empiric therapy became standard care. However, infectious complications remain the most…”
Get full text

Prospective non-interventional multicentre observational trial of first-line anti-cancer treatment in patients with metastatic renal cell cancer in Belgium by Cornelis, N., Vermassen, T., Schallier, D., Machiels, J.-P., Gil, T., Debruyne, P. R., D'hondt, R., Bols, A., Schrijvers, D., Mebis, J., Lumen, N., Rottey, S.

“…Objectives: Renal cell carcinoma (RCC) accounts for 2·4% of all new cancers in Belgium. Over the past decade, the armamentarium for systemic therapy of…”
Get full text

Secondary non-Hodgkin lymphoma of the ethmoid sinus after temozolomide by Broes, K, Van Ginderachter, L, Joosens, E, Maes, A, Theunissen, K, Schepers, S, Deben, K, Claes, J, Mebis, J, Cox, T

“…The paranasal sinuses are rarely the site of malignancy, especially non-Hodgkin lymphoma. In such cases, the ethmoid sinus is the second most frequently…”
Get more information

Sclerosing peritonitis : an unusual cause of ascites in a patient with systemic lupus erythematosus by PEPELS, M. J. A. E, PETERS, F. P. J, MEBIS, J. J. I. R, CEELEN, Th. L, HOOFWIJK, A. C. M, ERDKAMP, F. L. G

“…Sclerosing peritonitis is a rare condition characterised by fibrosis and adhesion of the peritoneum to loops of the small intestine. It is generally associated…”
Get full text

213P Photobiomodulation therapy for the management of chemotherapy-induced alopecia: Preliminary results of a randomized, controlled trial by Lodewijckx, J., Robijns, J., Claes, M., Mebis, J.

Get full text

Decreasing antibiotic resistance of Enterobacteriaceae by introducing a new antibiotic combination therapy for neutropenic fever patients by MEBIS, J, GOOSSENS, H, BRUYNEEL, P, SION, J. P, MEEUS, I, VAN DROOGENBROECK, J, SCHROYENS, W, BERNEMAN, Z. N

“…Prompt empiric antibiotic therapy is of critical importance for patients with neutropenic fever. However, a major concern with important clinical consequences…”
Get full text

CEFEPIME AND AMIKACIN AS EMPIRICAL THERAPY IN PATIENTS WITH FEBRILE NEUTROPAENIA: A SINGLE-CENTRE PHASE II PROSPECTIVE SURVEY by Mebis, J., Vandeplassche, S., Goossens, H., Berneman, Z.N.

“…The aim of the survey was to prospectively evaluate the effectiveness of the combination therapy cefepime and amikacin in the initial treatment of haematology…”
Get full text

Long-term epidemiology of bacterial susceptibility profiles in adults suffering from febrile neutropenia with hematologic malignancy after antibiotic change by Mebis, J, Jansens, H, Minalu, G, Molenberghs, G, Schroyens, Wa, Gadisseur, Ap, van de Velde, A, Vrelust, I, Goossens, H, Berneman, Zn

“…The aim of this study was to investigate the epidemiology and antibiotic susceptibility profiles of isolated bacterial organisms in relation to empiric…”
Get full text

Local and systemic effects of intraoperative whole-colon washout with 5 per cent povidone-iodine by Basha, G., Penninckx, F., Mebis, J., Filez, L., Geboes, K., Yap, P.

“…Background: Segmental intraluminal instillation of several tumoricidal agents including povidone–iodine has been advocated to prevent anastomotic recurrence…”
Get full text

Melanoma incidence trends in Limburg after screening and prevention campaigns by Vanstraelen, D, Deleu, H, Van Robays, J, Dhollander, D, Cloes, E, Lousberg, D, Kuipers, G, Adriaens, B, Mebis, J, Mathei, C, Buntinx, F

“…Abstract Background Malignant melanoma is a skin cancer of which the incidence is said to be raising in recent years. Prevention may result in decrease of the…”
Get full text

201P Afatinib for EGFR, HER2 or HER3 mutated solid tumors: A phase II Belgian precision study by Decoster, L., Aftimos, P.G., Rottey, S., Prenen, H., Collignon, J.J., Mebis, J., Canon, J-L., Fastenaekels, V., Cappoen, N., Joris, S.R., De Grève, J.

Get full text